PENPACT-1 (PENTA 9/PACTG 390): a randomised trial of protease inhibitor (PI) vs non-nucleoside reverse transcriptase inhibitor (NNRTI) combination antiretroviral (ART) regimens and viral load (VL) treatment switching strategies in HIV-1-infected ART-naive children age >30 days and < 18 years

THLBB104

---

Time: 13:30
Speaker: Ann Melvin





For more information on this presentation, including access to speaker presentations, please see the conference Programme-at-a-Glance page.